
Tata India Pharma & Healthcare Fund Direct Growth
Tata India Pharma & Healthcare Fund Direct Growth
as on 06 Nov 2026
Tata India Pharma & Healthcare Fund Direct Growth is a Equity mutual fund scheme launched on 28 Dec 2015. The current NAV stands at ₹38.9649 as of 06 Nov 2026. From the funds total AUM, its top holdings include Sun Pharmaceutical at 9.38%, Healthcare Global Enterprises at 5.87%, Divis Laboratories at 5.80%, Abbott at 5.41%, Cipla at 5.18%
Scheme Overview
- Inception Date : 28 Dec 2015
- AUM : ₹1,511.49 Cr
- 5Y Returns (CAGR) : 15.38%
- Expense Ratio : 1.07%
- Min. SIP : ₹100
- Min. Lumpsum : ₹5,000
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
5Y
₹ 32.73 L
3.50%
₹ 36.98 L
8.00%
₹ 45.32 L
15.38%
Total Investment
₹ 30,00,000
Returns
₹ 15,32,350 (15.38%)
Maturity Value
₹ 45,32,350
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 1,511.49 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹1,511.49 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 93.60% | ||
| Basic Materials | 3.96% | ||
| Consumer Defensive | 1.35% | ||
| Other | 0.70% | ||
| Financial Services | 0.40% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() S Sun Pharmaceutical | 9.38% | |
![]() H Healthcare Global Enterprises | 5.87% | |
![]() D Divis Laboratories | 5.80% | |
![]() A Abbott | 5.41% | |
![]() C Cipla | 5.18% | |
![]() M Max Healthcare Institute | 4.80% | |
![]() A Apollo Hospitals | 4.56% | |
![]() R Rainbow Childrens Medicare | 4.52% | |
![]() D Dr Reddys Laboratories | 4.02% | |
![]() M Mankind Pharma | 3.77% | |
![]() F Fortis Healthcare | 3.41% | |
![]() G GlaxoSmithKline Pharmaceuticals | 3.26% | |
![]() B Bayer Crop Science | 3.10% | |
![]() L Lupin | 2.76% | |
![]() S Sai Life Sciences | 2.73% | |
![]() S Syngene International | 2.65% | |
![]() A Alkem Laboratories | 2.42% | |
![]() J J B Chemicals and Pharmaceuticals | 2.24% | |
![]() G Global Health | 2.20% | |
![]() F FDC | 2.12% | |
![]() A Ajanta Pharma | 1.89% | |
![]() N Neuland Laboratories | 1.89% | |
![]() P Procter & Gamble Health | 1.80% | |
![]() D Dr. Lal Path Labs | 1.68% | |
![]() M Metropolis Healthcare | 1.64% | |
![]() P Pfizer | 1.63% | |
![]() S Sanofi | 1.46% | |
![]() G Gillette | 1.35% | |
![]() V Vijaya Diagnostic Centre | 1.14% | |
![]() T Torrent Pharmaceuticals | 1.02% | |
![]() C Concord Biotech | 0.77% | |
![]() D Dr. Agarwal's Health Care | 0.58% | |
![]() J Jubilant Pharmova | 0.55% | |
![]() S Sumitomo Chemical | 0.49% | |
![]() C Cash / Net Current Asset | 0.46% | |
![]() C Corona Remedies | 0.45% | |
![]() H HDFC Life Insurance | 0.40% | |
![]() P PI Industries | 0.36% | |
![]() A A) Repo | 0.23% | |
![]() I IPCA Laboratories | 0.00% | |
![]() A Aurobindo Pharma | 0.00% | |
![]() T Tata Chemicals | 0.00% |
Fund Comparison
Fund Details
52W High NAV
₹ 40.1562
Min. SIP Amount
₹ 100.00
Min. Lumpsum Amount
₹ 5,000.00
AUM (in Cr.)
₹ 1,511.49
Expense Ratio
1.07%
Lock-in Period
No Lock in Period
52W Low NAV
₹ 32.8027
Inception Date
28 Dec 2015
Fund Age
10 Yrs
Benchmark
BSE Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit load of 0.25% if redeemed within 30 days.
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Rajat Srivastava | BBA (Banking & Insurance), PGDM- IMT Ghaziabad |
Fund Objective
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
Tata Mutual Fund
No. of Schemes
61
Total AUM
₹ 2,20,729.89 Cr
Contact Details
1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051
Contact Details
1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051
FAQs
When was Tata India Pharma & Healthcare Fund launched?
What is the current NAV of Tata India Pharma & Healthcare Fund?
What is the AUM of Tata India Pharma & Healthcare Fund?
What is the rate of return of Tata India Pharma & Healthcare Fund?
- In the past 1Y: 8.40%
- In the past 3Y: 19.57%
- In the past 5Y: 15.38%
What is the expense ratio of Tata India Pharma & Healthcare Fund?
What is exit load of Tata India Pharma & Healthcare Fund?
What is the portfolio of Tata India Pharma & Healthcare Fund?
- Sun Pharmaceutical: 9.38%
- Healthcare Global Enterprises: 5.87%
- Divis Laboratories: 5.80%
- Abbott: 5.41%
- Cipla: 5.18%
Top 3 sectoral holdings include:
- Healthcare: 93.60%
- Basic Materials: 3.96%
- Consumer Defensive: 1.35%
How risky is investing in Tata India Pharma & Healthcare Fund?
Who is the fund manager Tata India Pharma & Healthcare Fund?
What is the minimum investment required in Tata India Pharma & Healthcare Fund?
How to invest in Tata India Pharma & Healthcare Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App











































